Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco

H El Annaz, P Recordon-Pinson… - AIDS research and …, 2012 - liebertpub.com
The emergence of viral-resistant strains is a major problem for the medical management of
HIV-infected individuals. The aim of this study was to characterize viral subtypes and drug …

Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali

A Keita, Y Sereme, S Pillet, S Coulibaly… - Journal of …, 2019 - academic.oup.com
Abstract Background To achieve the 90-90-90 targets assigned by UNAIDS, it is crucial to
monitor ART in HIV-1-infected patients, especially in resource-limited countries. Objectives …

HIV-1 drug resistance and third-line therapy outcomes in patients failing second-line therapy in Zimbabwe

C Chimbetete, D Katzenstein, T Shamu… - Open forum …, 2018 - academic.oup.com
Objectives To analyze the patterns and risk factors of HIV drug resistance mutations among
patients failing second-line treatment and to describe early treatment responses to …

Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from …

J Rusine, B Asiimwe-Kateera, J van de Wijgert… - PloS one, 2013 - journals.plos.org
Treatment outcomes of HIV patients receiving antiretroviral therapy (ART) in Rwanda are
scarcely documented. HIV viral load (VL) and HIV drug-resistance (HIVDR) outcomes at …

A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the …

GC Jayaraman, CP Archibald, J Kim… - JAIDS Journal of …, 2006 - journals.lww.com
Objectives: Published results on primary or transmitted HIV drug resistance may be biased
because they have been largely derived from specific cohort studies or higher risk …

High levels of pretreatment HIV-1 drug resistance mutations among south African women who acquired HIV during a prospective study

I Beesham, UM Parikh, JW Mellors… - JAIDS Journal of …, 2022 - journals.lww.com
Background: Pretreatment HIV drug resistance (PDR) undermines individual treatment
success and threatens the achievement of UNAIDS 95-95-95 targets. In many African …

Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras

W Murillo, G Paz-Bailey, S Morales… - Journal of Clinical …, 2010 - Elsevier
BACKGROUND: Transmitted drug resistance (TDR) reduces the efficacy of antiretroviral
treatment and is a public health concern. OBJECTIVES: To gain insight in the epidemiology …

Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort

S Pillay, RM Bland, RJ Lessells, J Manasa… - AIDS research and …, 2014 - Springer
Background Better understanding of drug resistance patterns in HIV-infected children on
antiretroviral therapy (ART) is required to inform public health policies in high prevalence …

High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana

PT Mokgethi, WT Choga, D Maruapula… - Frontiers in …, 2024 - frontiersin.org
Background Approximately 30,000 non-citizens are living with HIV in Botswana, all of whom
as of 2020 are eligible to receive free antiretroviral treatment (ART) within the country. We …

Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania

F Mosha, J Ledwaba, F Ndugulile, P Nsubuga… - The Journal of Infection …, 2014 - jidc.org
Abstract Introduction: In Tanzania, the follow-up on antiretroviral therapy (ART) response is
based on clinical outcomes. We investigated virological response and ARV resistance …